Ibuprofeno Pediátrico B. Braun (Ibuprofen)

Ibuprofen works by non‑selectively inhibiting the cyclo‑oxygenase enzymes COX‑1 and COX‑2. This inhibition blocks the conversion of arachidonic acid into prostaglandins, which are key mediators of pain, fever, and inflammation. Lower prostaglandin levels reduce the sensitivity of pain receptors, lower the hypothalamic set‑point for temperature, and diminish inflammatory swelling.

The appropriate dose of Ibuprofeno Pediátrico B. Braun is determined by the prescribing clinician based on the child’s age, weight, clinical condition, and renal or hepatic function. The healthcare professional calculates the exact milligram amount and infusion rate to achieve the desired therapeutic effect while minimizing risk.

Safety of intravenous ibuprofen during pregnancy or lactation has not been fully established, and the product is generally avoided unless the potential benefit outweighs the risk. Clinicians should evaluate each case individually, and alternative therapies may be preferred for pregnant or nursing mothers.

To place an order, submit an enquiry on the product page at gnhindia.com, specifying the required quantity. GNH India works with hospitals, pharmacies, and procurement teams worldwide, verifies trade or institutional credentials, and then provides pricing, availability, shipping details (including any cold‑chain requirements), and necessary import documentation.

The primary alternative to intravenous ibuprofen is intravenous acetaminophen, which provides antipyretic and analgesic effects but has minimal anti‑inflammatory activity. Ibuprofen offers stronger anti‑inflammatory action and may be preferred when inflammation is a major component, while acetaminophen is often chosen for patients at higher risk of gastrointestinal or renal side effects.

Store the intravenous solution at ambient temperature, preferably below 25 °C. Keep the vial in its original packaging, protect it from moisture and direct sunlight, and avoid freezing. Follow any additional handling instructions provided on the label to maintain product stability.

Ibuprofeno Pediátrico B. Braun is administered by slow intravenous infusion under the supervision of qualified medical staff. The infusion rate and total volume are calculated by the prescriber based on the child’s weight and clinical need, and the medication is given through a sterile IV line using aseptic technique.

Serious risks include gastrointestinal bleeding or ulceration, acute kidney injury, severe allergic reactions such as anaphylaxis, and hepatic dysfunction. Clinicians should monitor for signs of bleeding, changes in urine output, rash or breathing difficulty, and abnormal liver function tests, especially in high‑risk patients.

Children with known hypersensitivity to ibuprofen, other NSAIDs, or any component of the formulation should not receive this product. It is also contraindicated in patients with active gastrointestinal bleeding, severe renal impairment, or severe hepatic disease, and should be used with caution in those with a history of asthma triggered by NSAIDs.